Overall, comparable results were also obtained in prostate cancer by Ma and colleagues [10], which showed that FAM46C overexpression reduced AKT phosphorylation in the DU145 prostate cancer cell line model. This evidence concerns the gene AKT1 and prostate carcinoma.